Literature DB >> 15944266

CD8 cell division maintaining cytotoxic memory occurs predominantly in the bone marrow.

Elisabetta Parretta1, Giuliana Cassese, Pasquale Barba, Angela Santoni, John Guardiola, Francesca Di Rosa.   

Abstract

Long-term persistence of Ag-experienced CD8 cells, a class of T lymphocytes with cytotoxic function, contributes to immunological memory against intracellular pathogens. After Ag clearance, memory CD8 cells are maintained over time by a slow proliferation, primarily cytokine driven. In this article, we show that the bone marrow (BM) is the crucial organ where such basal division of memory CD8 cells occurs. BM memory CD8 cells contain a higher percentage of proliferating cells than their corresponding cells in either spleen or lymph nodes from C57BL/6 mice. This occurs both in the case of memory-phenotype CD44(high) CD8 cells and in the case of Ag-specific memory CD8 cells. Importantly, the absolute number of Ag-specific memory CD8 cells dividing in the BM largely exceeds that in spleen, lymph nodes, liver, and lung taken together. In the BM, Ag-specific memory CD8 cells express lower levels of CD127, i.e., the alpha-chain of IL-7R, than in either spleen or lymph nodes. We interpret these results as indirect evidence that Ag-specific memory CD8 cells receive proliferative signals by IL-7 and/or IL-15 in the BM and propose that the BM acts as a saturable "niche" for the Ag-independent proliferation of memory CD8 cells. Taken together, our novel findings indicate that the BM plays a relevant role in the maintenance of cytotoxic T cell memory, in addition to its previously described involvement in long-term Ab responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15944266     DOI: 10.4049/jimmunol.174.12.7654

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

1.  Bone marrow vaccination: a novel approach to enhance antigen specific antitumor immunity.

Authors:  Stephanie Fresnay; Xiaoyu Zhang; Scott E Strome; Duane A Sewell
Journal:  Vaccine       Date:  2011-09-25       Impact factor: 3.641

Review 2.  Memory CD4 T cells: generation, reactivation and re-assignment.

Authors:  Megan K L MacLeod; John W Kappler; Philippa Marrack
Journal:  Immunology       Date:  2010-03-16       Impact factor: 7.397

3.  Immunity and protection, the unfolding of a tale.

Authors:  Maurizio Zanetti
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 4.  [Stromal cells as coordinators of adaptive immune response and immunological memory].

Authors:  A E Hauser
Journal:  Z Rheumatol       Date:  2013-12       Impact factor: 1.372

Review 5.  Heterogeneous memory T cells in antiviral immunity and immunopathology.

Authors:  David Verhoeven; John R Teijaro; Donna L Farber
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

6.  Sympathetic Enhancement of Memory T-Cell Homing and Hypertension Sensitization.

Authors:  Liang Xiao; Luciana Simao do Carmo; Jason D Foss; Wei Chen; David G Harrison
Journal:  Circ Res       Date:  2020-01-13       Impact factor: 17.367

7.  Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells.

Authors:  J Joseph Melenhorst; Michael C Milone; Saba Ghassemi; Selene Nunez-Cruz; Roddy S O'Connor; Joseph A Fraietta; Prachi R Patel; John Scholler; David M Barrett; Stefan M Lundh; Megan M Davis; Felipe Bedoya; Changfeng Zhang; John Leferovich; Simon F Lacey; Bruce L Levine; Stephan A Grupp; Carl H June
Journal:  Cancer Immunol Res       Date:  2018-07-20       Impact factor: 11.151

8.  Dendritic cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation.

Authors:  Spencer W Stonier; Lisa J Ma; Eliseo F Castillo; Kimberly S Schluns
Journal:  Blood       Date:  2008-09-23       Impact factor: 22.113

9.  Tumor vaccine composed of C-class CpG oligodeoxynucleotides and irradiated tumor cells induces long-term antitumor immunity.

Authors:  Petra Cerkovnik; Barbara Jezersek Novakovic; Vida Stegel; Srdjan Novakovic
Journal:  BMC Immunol       Date:  2010-09-13       Impact factor: 3.615

10.  Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity.

Authors:  Juan R Cubillos-Ruiz; Xavier Engle; Uciane K Scarlett; Diana Martinez; Amorette Barber; Raul Elgueta; Li Wang; Yolanda Nesbeth; Yvon Durant; Andrew T Gewirtz; Charles L Sentman; Ross Kedl; Jose R Conejo-Garcia
Journal:  J Clin Invest       Date:  2009-07-13       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.